2021
DOI: 10.1212/nxg.0000000000000609
|View full text |Cite
|
Sign up to set email alerts
|

Early-Onset Cerebral Amyloid Angiopathy and Alzheimer Disease Related to an APP Locus Triplication

Abstract: Background and ObjectiveTo report a triplication of the amyloid-β precursor protein (APP) locus along with relative messenger RNA (mRNA) expression in a family with autosomal dominant early-onset cerebral amyloid angiopathy (CAA) and Alzheimer disease (AD).MethodsFour copies of the APP gene were identified by quantitative multiplex PCR of short fluorescent fragments, fluorescent in situ hybridization (FISH), and array comparative genomic hybridization. APP mRNA levels were assessed using reverse-transcription–… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 12 publications
0
17
0
Order By: Relevance
“…The only disease in which APP has been previously studied is Alzheimers Disease, where APP is well known to play a part in the pathogenesis. The connection of increased APP levels and dementia is underlined by the fact that triplications of APP in humans and overexpression of APP in mice have been associated with early onset of cognitive impairment (Kreis et al, 2021;Grangeon et al, 2021). However, to the best of our knowledge, this study is the first to find lower APP levels in a patient group, and the first to investigate the relationship of APP and fatigue in any disease.…”
Section: Discussionmentioning
confidence: 79%
“…The only disease in which APP has been previously studied is Alzheimers Disease, where APP is well known to play a part in the pathogenesis. The connection of increased APP levels and dementia is underlined by the fact that triplications of APP in humans and overexpression of APP in mice have been associated with early onset of cognitive impairment (Kreis et al, 2021;Grangeon et al, 2021). However, to the best of our knowledge, this study is the first to find lower APP levels in a patient group, and the first to investigate the relationship of APP and fatigue in any disease.…”
Section: Discussionmentioning
confidence: 79%
“…Increased expression of APP leads to Alzheimer’s disease, where Aβ directly contributes to pathologies. For example, three copies of APP in Down’s Syndrome ( Wisniewski et al, 1985 ) as well as local duplications ( Rovelet-Lecrux et al, 2006 ; Sleegers et al, 2006 ) and triplications ( Grangeon et al, 2021 ) are causative of dementia.…”
Section: Discussionmentioning
confidence: 99%
“…Trisomy of chromosome 21 in Down’s syndrome (DS) leads to three copies of APP and a concurrent high incidence of Alzheimer’s disease in DS patients ( Wisniewski et al, 1985 ). Additionally, duplications ( Rovelet-Lecrux et al, 2006 ; Sleegers et al, 2006 ) and triplications ( Grangeon et al, 2021 ) of the local APP gene territory cause fAD. In contrast, people living with one functional copy of APP are asymptomatic ( Klein et al, 2016 ) and mutations that reduce amyloidogenic processing of APP can be protective against AD ( Jonsson et al, 2012 ).…”
Section: Introductionmentioning
confidence: 99%
“…The Flierl research team found that the higher vulnerability of Parkinson's disease and stress sensitivity of neuronal precursor cells carry an α-synuclein gene triplication (Flierl et al, 2014 ). Grangeon et al ( 2021 ) discovered that early-onset cerebral amyloid angiopathy and Alzheimer Disease (AD) were related to an amyloid precursor protein (App) gene triple amplification. Breunis et al ( 2008 ) reported that the copy number variations of FCGR2C gene promoted idiopathic thrombocytopenic purpura.…”
Section: Introductionmentioning
confidence: 99%